RareCyte
Latest round
- Series G
Last raised
- Aug 2021
Total raised
- $46M
Investors
- 6
About RareCyte
Based in the US, RareCyte, Inc.Founded in 2009, RareCyte, Inc. is headquartered in Seattle, US, and specializes in spatial biology and liquid biopsy technologies.RareCyte offers products that include the Orion Spatial Imager and CyteFinder, both designed to facilitate high-performance imaging and rare cell analysis.The company's revenue is primarily generated through the sale of its imaging instruments and assay development services. Direct sales to research institutions and biotechnology companies include equipment purchases and associated services for clinical trials.In June 2024, RareCyte, Inc. Future growth plans include the launch of new products aimed at enhancing spatial biology solutions and an expansion into key markets across North America, Europe, and Asia within the next year.
Who invested in RareCyte
6 investors across 2 rounds
See all investors in RareCyte
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about RareCyte
Who invested in RareCyte?
RareCyte has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has RareCyte raised?
RareCyte has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did RareCyte last raise money?
RareCyte's most recent round on record is a Series G, in Aug 2021.
What does RareCyte do?
Based in the US, RareCyte, Inc.
Where is RareCyte headquartered?
RareCyte is headquartered in Seattle, US.
Which VCs invest in companies like RareCyte?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at RareCyte's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series G
Raising like RareCyte? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.